
Please try another search
Illumina (NASDAQ:ILMN) shares plummeted 22% after-hours following the company’s reported Q2 results, with EPS of $0.57 coming in worse than the consensus estimate of $0.64. Revenue grew 3% year-over-year (up 5% on a constant currency basis) to $1.16 billion, compared to the consensus estimate of $1.22 billion.
"Our second quarter results did not meet our expectations as challenges in a complex macroeconomic environment more than offset the growth we continue to see in sequencing runs on our platforms," said Francis deSouza, CEO of Illumina.
The analysts provided their full 2022-year outlook, expecting EPS to be in the range of $2.75-$2.90, worse than the consensus estimate of $4.12. Consolidated revenue growth is expected to be in the range of 4% to 5%.
The company expects 2022 Core Illumina revenue growth to be in the range of 3.5-4.5%, and GRAIL revenue to be in the range of $50-$70 million.
By Davit Kirakosyan
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.